Yanbin Fu

Highlights

18

8

1 grant

KP
A deep longitudinal analysis of next generation influenza vaccines in older adults.
National Institute of Allergy and Infectious Diseases · 2022–2026 · via The Jackson Laboratory for Genomic Medicine
U01AI165452-01

Completed grants (7)

KP
CRUIVV - Center for Research on Universal Influenza Virus Vaccines (Option 5)
National Cancer Institute · 2024–2025 · via Icahn School of Medicine at Mount Sinai
75N93019C00051
KP
PanCoVac - Pan-coronavirus Vaccine Consortium
National Institute of Allergy and Infectious Diseases · 2021–2025 · via University of Wisconsin
P01AI165077-01
KP
CRUIVV - Center for Research on Universal Influenza Virus Vaccines (Option 4)
National Cancer Institute · 2023–2024 · via Icahn School of Medicine at Mount Sinai
75N93019C00051
KP
CRUIVV - Center for Research on Universal Influenza Virus Vaccines (Option 3)
National Cancer Institute · 2022–2023 · via Mount Sinai School of Medicine
75N93019C00051
KP
Turning influenza into measles via MOsaic Natural
Bill & Melinda Gates Foundation · 2021–2023
INV-029364
KP
CRUIVV - Center for Research on Universal Influenza Virus Vaccines (Option 17C)
National Cancer Institute · 2021–2023 · via Mount Sinai School of Medicine
75N93019C00051
KP
SARS-CoV-2 B-Cell epitope mapping supplement
National Institute of Allergy and Infectious Diseases · 2021–2023 · via The Washington University (dba Washington University School of Medicine)
75N93019C00062